Search

Author/Creator Onsum, Matthew

1. 323 Systemic administration of ladiratuzumab vedotin alone or in combination with pembrolizumab results in significant immune activation in the tumor microenvironment in metastatic breast cancer patients. (9th November 2020)

Authors:
Pusztai, Lajos; Lu, Hailing; Hale, Christopher; Grosse-Wilde, Anne; Specht, Jennifer; Modi, Shanu; Han, Hyo; Cortes, Javier; Oliveira, Mafalda; Garfin, Phillip; Wang, Zejing; Onsum, Matthew
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A198
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis. (May 2021)

Authors:
Kim, Youn H.; Prince, H. Miles; Whittaker, Sean; Horwitz, Steven M.; Duvic, Madeleine; Bechter, Oliver; Sanches, Jose A.; Stadler, Rudolf; Scarisbrick, Julia; Quaglino, Pietro; Zinzani, Pier Luigi; Wolter, Pascal; Eradat, Herbert; Pinter-Brown, Lauren C.; Ortiz-Romero, Pablo L.; Akilov, Oleg E.; ...
Journal:
European journal of cancer
Issue:
Volume 148(2021)
Page Start:
411
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search